QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Poster on missed opportunities to reduce fragility fractures to be presented at ASBMR 2018
The poster ‘Multiple missed opportunities to reduce key fragility fractures: can we afford to continue to ignore the facts?’, co-authored by Quantify’s Jonas Banefelt and Gustaf Ortsäter, will be presented at the 2018 American Society for Bone and Mineral Research Annual Meeting.
The meeting will be held September 28 – October 1 in Montreal, Canada.
Poster on the cost-effectiveness of Patiromer treatment for hyperkalemia in Sweden to be presented at ISPOR Europe 2018
The abstract ‘A cost-effectiveness analysis of RAASI-enabling Patiromer for the treatment of hyperkalemia in Sweden’, co-authored by Quantify’s Julia Widén and Petros Nousios, has been accepted as a poster presentation at ISPOR Europe 2018.
The poster will be presented by Julia Widén, 14 November 2018 in Barcelona, Spain.
Quantify will present late-breaking asthma research for the NORDSTAR research platform at ERS International Congress
Quantify’s Kirk Geale and Maria Lindh will attend the ERS International Congress 2018 held in Paris, France (15-19 September) to present late-breaking asthma research for the NORDSTAR research platform.
NORDSTAR is a pioneering, cross-border, multi-party collaboration that aims to steer and facilitate novel, retrospective asthma research to improve management of the disease. Characteristics of patients in Finland and Sweden will be described at […]
Poster on Ecological Benefits of Health Technologies to be presented at ISPOR Asia Pacific 2018
The abstract “Ecological benefits of health technologies – How to consider public value in funding decisions?”, co-authored by Carolin Miltenburger and Quantify’s Fredrik Borgström, has been accepted as a poster presentation at ISPOR Asia Pacific 2018.
The poster will be presented by Carolin Miltenburger, Miltenburger Consulting, 11 September 2018 in Tokyo, Japan.